Drug Topics

SEPTEMBER 15, 2022

Improvements in atopic dermatitis symptoms were seen in children taking dupilumab, with minimal adverse events.

281

281

PharmaVoice

SEPTEMBER 15, 2022

Sonara Health’s inexpensive, specially engineered label and web app allow for at-home, digitally supervised dosing of high-cost or high-risks drugs.

Labelling 246

Labelling 246

Drug Topics

SEPTEMBER 15, 2022

William J. Muller, MD, PhD, discusses COVID-19 vaccinations for children of all ages and describes what is on the horizon for RSV.

Vaccines 247

Vaccines 247

STAT

SEPTEMBER 15, 2022

Artificial intelligence is a transformative tool in the workplace — except when it isn’t. For top managers, state-of-the art AI tools are a no-brainer: in theory, they increase revenues, decrease costs, and improve the quality of products and services. But in the wild, it’s often just the opposite for frontline employees who actually need to integrate these tools into their daily work.

144

144

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

SEPTEMBER 15, 2022

Deucravacitinib is a selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, which is a member of the Janus kinase (JAK) family.

123

123

pharmaphorum

SEPTEMBER 15, 2022

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a “possible unlawful use of a patent to reduce competitive pressure.” The Swiss Competition Commission (COMCO) arrived unexpectedly at Novartis at dawn on Tuesday morning, to gather information on an unidentified dermatology drug, as part of a wider investigation into the drugmaker by the European Commission.

118

118

Drug Store News

SEPTEMBER 15, 2022

According to a survey by Reach 3 Insights, 80% of Americans say that rising prices have driven them to purchase more store-brand products.

110

110

Pharmacy Times

SEPTEMBER 15, 2022

Researchers have identified hydroquinine as a potential treatment against drug-resistant bacteria, which can cause infections with a 70% mortality rate.

123

123

Pharmaceutical Technology

SEPTEMBER 15, 2022

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. The top 13 players reported more than 10% revenue growth, with BioNTech (3,834.4%), Moderna (2,199.1%), Pfizer (95.2%) and Regeneron Pharmaceuticals (89.1%) reporting a more than 80% year-on-year (YoY) revenue growth from 2020 to 2021, according to GlobalData’s Pharma Intelligence Centre Companies Database.

Vaccines 108

Vaccines Documentation Compounding FDA 108

Pharmacy Times

SEPTEMBER 15, 2022

Alopecia areata is an autoimmune disease with an underlying immuno-inflammatory pathogenesis.

FDA 123

FDA 123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Tutor

SEPTEMBER 15, 2022

AN APPROACH TO THE HAIR FALL & HAIR GROWTH MANAGEMENT. About Authors Avdesh Thassu. MPharm (Nat. Chem.); MBA(Mkt.). Associate Vice President. Global Regulatory Affairs, Emami Limited, 7044455199. athassu@hotmail.com. Chandra Mohan Nandi. MSc. (Organic Chem.). Deputy Manager, Global Regulatory Affairs, Emami Limited, 9051706947 chandramohannandi@yahoo.in. admin.

105

105

pharmaphorum

SEPTEMBER 15, 2022

The potential for technology to transform the way we deliver healthcare is nothing new. We’ve been discussing it for some years now and are starting to see more widespread adoption, particularly post-pandemic. But the area where I believe technology can have the greatest impact – and where there is still plenty of work to do – is women’s health. Today, women spend around a quarter of their lives in poor health or disability, compared with one fifth for men.

105

105

STAT

SEPTEMBER 15, 2022

The Swiss Competition Commission has begun an investigation into Novartis over the possible unlawful use of a patent to block competitors for some of its medicines, the latest instance in which European authorities have probed drug companies for antitrust infractions. Earlier this week, the Swiss agency conducted a dawn raid on Novartis headquarters in Basel, Switzerland, seeking information about efforts the company allegedly made to protect a drug for an unspecified skin treatment.

98

98

European Pharmaceutical Review

SEPTEMBER 15, 2022

Investing close to €300 million, Takeda plans to construct a new state-of-the-art production facility for plasma-derived therapies and a net-zero carbon emissions warehouse in Lessines, Belgium – the largest investment Takeda has ever made in the country. The investment is part of the company’s global effort to implement the most innovative technologies and most sustainable processes at its manufacturing sites.

Packaging 98

Packaging 98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

SEPTEMBER 15, 2022

WASHINGTON — A Democratic House lawmaker with oversight authority is calling for an investigation into the largest for-profit hospital chain in the country, HCA Healthcare. Rep. Bill Pascrell (D-N.J.), the chair of the House Ways and Means Committee’s subcommittee on oversight, this week asked the Department of Health and Human Services to investigate whether HCA is improperly admitting emergency department patients to the hospital when they don’t need inpatient care.

Hospitals 98

Hospitals 98

European Pharmaceutical Review

SEPTEMBER 15, 2022

According to Novartis, Kisqali ® (ribociclib) plus endocrine therapy in the first-line setting added nearly a year of additional overall survival (OS) benefit in a subgroup of patients with aggressive forms of hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer (aBC). The pooled exploratory analysis from the MONALEESA Phase III programme revealed that patients with visceral metastases, including liver metastases and multiple metastatic

98

98

STAT

SEPTEMBER 15, 2022

A host of health tech startups and companies are advertising their apps and platforms as key solutions to improving diversity in clinical trials, promising to help researchers improve their outreach, enrollment, and retention — what one researcher calls a “modern-day gold rush.” The Power platform focuses on breaking down medical jargon and helping users connect with trial sponsors nearby.

98

98

Drug Store News

SEPTEMBER 15, 2022

The beauty category, most notably the skin care space, has seen a massive resurgence in the demand for environmentally friendly, clean, vegan and cruelty-free products.

97

97

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

SEPTEMBER 15, 2022

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

98

98

ISPE

SEPTEMBER 15, 2022

Annex 1 Implementation Strategies. Trudy Patterson. Thu, 09/15/2022 - 13:50. iSpeak Blog. iSpeak. Annex 1 Implementation Strategies. Thomas Zimmer, PhD. 15 September 2022. Annex 1 of the EC GMP Guide " Manufacture of Sterile Medicinal Products " has a long history. First published in 1989, there have been a total of 5 adaptations in 1996, 2003, 2005, 2007 and 2009, but no complete revision.

Documentation 97

Documentation FDA 97

STAT

SEPTEMBER 15, 2022

Rise and shine, everyone, another busy day is on the way. This morning is getting off to a fabulous start, though, as a delightfully cool breeze and warm sun are enveloping the subdued Pharmalot campus, where the official mascot is snoozing nearby. As always, we are quaffing some cups of stimulation — chocolate raspberry is our choice du jour — and assembling some tidbits for your pleasure.

97

97

Drug Store News

SEPTEMBER 15, 2022

Utilizing Amazon Customer Engagement’s Tailored Audiences, sellers can now increase their email marketing reach and build brand loyalty, the company said.

96

96

Pharmacy Times

SEPTEMBER 15, 2022

Services such as managing/updating patient programs and working with non-profits can go a long way in healthcare education for patients.

73

73

Drug Store News

SEPTEMBER 15, 2022

Dr. Scholl’s is working with former head football coach and analyst Rex Ryan and surgeon Brad Schaeffer of TLC’s “My Feet Are Killing Me” on the launch of its Instant Cool Athlete’s Foot solutions.

94

94

Pharmacy Times

SEPTEMBER 15, 2022

Part A results from the 2-part LILAC study show that the therapy significantly reduced disease activity based on active joint count in individuals compared with the placebo.

65

65

Drug Store News

SEPTEMBER 15, 2022

Generic Faslodex is used to treat advanced-stage, hormone receptor-positive, HER2-negative breast cancer.

52

52

Pharmacy Times

SEPTEMBER 15, 2022

Panelists discuss pharmacist involvement in effective management, including disease burden and quality of life.

56

56

Outsourcing Pharma

SEPTEMBER 15, 2022

Faeth Therapeutics aims to remove roadblocks to âanyone other than the wealthiest patientsâ through remote trial partnership.

52

52

pharmaphorum

SEPTEMBER 15, 2022

Pfizer’s close-fought contest with GSK to bring a next-generation meningitis vaccine to market has entered the final rounds, with the former ahead on points following the readout of a pivotal phase 3 clinical trial. Both companies are developing MenABCWY vaccines that cover all five meningococcal strains in one go as an alternative to separate vaccinations, in the hope of simplifying immunisation schedules and reducing the number of injections needed, as well as potentially enhancing uptak

Vaccines 52

Vaccines FDA 52

Outsourcing Pharma

SEPTEMBER 15, 2022

Australian CRO Avance Clinical has expanded in North America by acquiring C3 Research Associates, positioning it to continue supporting sponsors as they move into later-phase studies that need US sites.

52

52

PharmExec

SEPTEMBER 15, 2022

In episode 117, Helen Sabzevari, CEO of Precigen, discusses her drive to study science as a Persian-born woman, the opportunities she’s had to research immunology, and how she’s now developing next-generation CAR-T treatments for cancer, in addition to other therapies.

52

52

Pharmaceutical Technology

SEPTEMBER 15, 2022

Research by GlobalData (Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition) shows that containment facilities are in high demand as the use of cytotoxic drugs continues to grow. The same research also shows that all the top small molecule API contract manufacturing organisations (CMOs) increased the number of containment facilities they owned between 2019 and 2021, while at the same time, many companies decreased non-containment, small molecule manufacturing.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

SEPTEMBER 15, 2022

The Clinical Data Interchange Standards Consortium (CDISC) is dedicated to the improvement of medical research through data standardization. CDISC has produced a suite of standards that should be used to standardize content from planning and data collection through to data analysis and reporting. The United States Food and Drug Administration (FDA) now requires studies to be submitted in this standardized format.

FDA 52

FDA Communication 52